NeuroPace (NPCE) Other Working Capital Changes (2020 - 2026)
NeuroPace's (NPCE) quarterly Other Working Capital Changes came in at -$513000.0 in Q1 2026, down 513.71% year-on-year from $124000.0 in Q1 2025, and down 153.11% quarter-over-quarter from $966000.0 in Q4 2025.
NeuroPace (NPCE) Other Working Capital Changes (2020 - 2026) Analysis & Trends
NeuroPace's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$513000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 513.71% year-over-year to -$513000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 6468.75% decrease from a year earlier, with the FY2025 full-year figure at -$414000.0, up 22.47% from the prior year.
- Other Working Capital Changes slipped to -$513000.0 in Q1 2026 per NPCE's latest filing, from $966000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q4 2023 and bottomed at -$809000.0 in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$178000.0 (2024), against an average of -$49352.9.
- Across the five-year window, Other Working Capital Changes jumped 229.59% in 2023 and sank 513.71% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$534000.0 in 2022, then plunged by 164.98% to -$1.4 million in 2023, then surged by 147.56% to $673000.0 in 2024, then soared by 43.54% to $966000.0 in 2025, then sank by 153.11% to -$513000.0 in 2026.
- Per Business Quant, the three latest NPCE Other Working Capital Changes figures stand at -$513000.0 (Q1 2026), $966000.0 (Q4 2025), and -$1.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | -809,000.00 |
| Dec 31, 2025 | -809,000.00 |
| Dec 31, 2025 | -809,000.00 |
| Sep 30, 2025 | 537,000.00 |
| Sep 30, 2025 | 537,000.00 |
| Sep 30, 2025 | 537,000.00 |
| Jun 30, 2025 | -521,000.00 |
| Jun 30, 2025 | -521,000.00 |
| Jun 30, 2025 | -521,000.00 |
| Mar 31, 2025 | -150,000.00 |
| Mar 31, 2025 | -150,000.00 |
| Mar 31, 2025 | -150,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Sep 30, 2024 | 32,000.00 |